Rise and shine, everyone, another busy day is on the way. We can always tell, because the short person is hovering over a laptop and the official mascot is bounding about the snowy Pharmalot campus. As for us, we are pursuing the usual routine of firing up the coffee kettle — our choice today is maple bourbon — and foraging for items of interest. So here they are. We hope your journey goes well today and you conquer the world, such as it is. Meanwhile, stay in touch and stay safe — wear a mask. …

The House Energy and Commerce Oversight and Investigations subcommittee will hold a hearing on Feb. 23 about efforts by Covid-19 vaccine makers to ramp up production. Officials from AstraZeneca (AZN), Johnson & Johnson (JNJ), Moderna (MRNA), Novavax (NVAX), and Pfizer (PFE) have all been called to testify. The hearing will be held amid intensifying questions about available supplies, distribution problems in the U.S., and a global scramble for vaccines.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

What is it?

STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What’s included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Source: STATNEWS.COM

Leave a Reply

ArabicChinese (Simplified)EnglishFrenchGermanItalianJapanesePortugueseRussianSpanish

[mc4wp_form id="449"]